FFO
OLMA icon

Fortitude Family Office’s Olema Pharmaceuticals OLMA Stock Holding History

Fortitude Family Office’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-319
Closed -$3.81K – 1359
2024
Q3 		$3.81K Hold
319
– – ﹤0.01% 870
2024
Q2 		$3.45K Hold
319
– – ﹤0.01% 702
2024
Q1 		$3.61K Hold
319
– – ﹤0.01% 710
2023
Q4 		$4.48K Buy
+319
New +$4.29K ﹤0.01% 702

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Fortitude Family Office's OLMA Position: Q4 2024 in Review

Fortitude Family Office sold out of Olema Pharmaceuticals (OLMA) in Q4 2024, closing a stake of 319 shares — an estimated $3.81K sold.

Fortitude Family Office first reported a position in OLMA in Q4 2023 and held it in 4 quarters. The position peaked at $4.48K in Q4 2023. 156 funds tracked by Wall St. Rank hold OLMA as of Q4 2024.

  • Fortitude Family Office reported no remaining Olema Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Fortitude Family Office sold 319 Olema Pharmaceuticals shares in Q4 2024, an estimated $3.81K.
  • Fortitude Family Office first reported a position in Olema Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Fortitude Family Office's Olema Pharmaceuticals position peaked at $4.48K in Q4 2023.
  • 156 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2024.

Based on Fortitude Family Office's 13F filing for Q4 2024, filed 10 Jan 2025.